Viewing Study NCT03573960


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2025-12-26 @ 12:44 AM
Study NCT ID: NCT03573960
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-15
First Post: 2018-06-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Sponsor: Eisai Pharmaceuticals India Pvt. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module